09 November 2026
: Case report
[In Press] Sequential Management of Stage 3/Type III Lipedema With a Ketogenic Dietary Phase Followed by Adjunctive Photothermal Biomodulated Autologous Platelet-Rich Plasma: A Descriptive Case Report
Unusual setting of medical care
Isabel Bové Farré1ABCDEFG, Margherita Falcomer1ABCDEF, Natalia de Cabo Bové1BCDEDOI: 10.12659/AJCR.954921
Am J Case Rep In Press; DOI: 10.12659/AJCR.954921
Available online: 2026-11-09, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Lipedema is a chronic adipose tissue disorder associated with pain, tissue fibrosis, and functional impairment. Evidence supporting nutritional strategies and adjunctive local treatments remains limited.
CASE REPORT
A 47-year-old woman with stage 3/type III lipedema and obesity underwent an individualized ketogenic, carbohydrate-restricted, normoprotein dietary phase for 7 months. This was followed by a 4-month local intervention phase including 4 monthly sessions of multipuncture administration of autologous platelet-rich plasma after ex vivo photothermal biomodulation with blue light (467 nm, 2 J/cm², 37°C, 10 min). Body composition was assessed by bioelectrical impedance analysis, fat thickness by ultrasonography, pain by visual analog scale, and patient-reported global aesthetic improvement at the final visit. Over 11 months, body weight decreased from 103.4 to 72.0 kg, body mass index from 37.1 to 25.8 kg/m², fat mass from 47.2 to 23.2 kg, and visceral fat level from 12 to 6. Subcutaneous, preperitoneal, and omental fat thickness also decreased. Pain decreased from 9/10 at baseline to 5/10 at final assessment; patient-reported global aesthetic improvement was 5/5, and no adverse events were documented.
CONCLUSIONS
Most objective changes occurred during the dietary phase. During the local intervention phase, the diet continued to be modified, and body weight decreased further, confounding attribution of second-phase outcomes specifically to photothermal biomodulated platelet-rich plasma. Pain was not assessed at the end of the dietary phase. Therefore, the independent contribution of photothermal biomodulated platelet-rich plasma to second-phase outcomes cannot be determined. This case should be interpreted as a descriptive report rather than as evidence of efficacy, mechanism, or additive benefit.
Keywords: Lipedema; Low-Level Light Therapy; Platelet-Rich Plasma; Ultrasonography
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954600
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954889
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954405
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953611
Most Viewed Current Articles
07 Dec 2021 : Case report
28,714,025
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
181,538
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
125,043
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
08 May 2026 : Case report
97,330
DOI :10.12659/AJCR.952158
Am J Case Rep 2026; 27:e952158






